Vir Biotechnology
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $11,278 | $2,380 | $3,075 | $56,376 |
Gross Profit | 10,594 | 2,330 | -1,237 | 51,800 |
EBITDA | -118,208 | -215,696 | -128,095 | -75,564 |
EBIT | -121,094 | -218,592 | -132,355 | -80,081 |
Net Income | -104,589 | -213,717 | -138,378 | -65,275 |
Net Change In Cash | 11,278 | 2,380 | 3,075 | 56,376 |
Free Cash Flow | -90,042 | -173,836 | -78,513 | -111,262 |
Cash | 222,947 | 257,948 | 310,810 | 174,046 |
Basic Shares | 136,246 | 136,653 | 136,233 | 135,280 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $74,205 | $86,180 | $1,580,472 | $1,087,068 |
Gross Profit | 73,360 | 83,415 | 1,434,153 | 1,021,203 |
EBITDA | -537,611 | -664,854 | 833,068 | 420,751 |
EBIT | -552,170 | -684,305 | 817,576 | 408,768 |
Net Income | -521,960 | -615,061 | 515,837 | 528,584 |
Net Change In Cash | 74,205 | 86,180 | 1,580,472 | 1,087,068 |
Cost of Revenue | -88,072 | |||
Free Cash Flow | -453,653 | -800,358 | 1,595,225 | -69,406 |
Cash | 312,332 | 241,576 | 848,631 | 347,815 |
Basic Shares | 136,246 | 134,130 | 134,810 | 133,437 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.76 |
2024-09-30 | -$1.56 |
2024-06-30 | -$1.02 |
2024-03-31 | -$0.48 |
